Clinical Trial Update: Fecal Microbial Transplants for the Treatment of Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial is investigating fecal microbiota transplant as a treatment for pancreatic ductal adenocarcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: RECRUITING